W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income · posted Oct 20, 2025

Bills named in this filing 1

Lobbying activity 2

Health Issues

Education about access to HIV medicines. Education about the 340(b) program.

Medicare/Medicaid

Implementation H.R.5376 - Inflation Reduction Act of 2022. Public Law 119-21: One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.